Aliases & Classifications for Pityriasis Rosea

MalaCards integrated aliases for Pityriasis Rosea:

Name: Pityriasis Rosea 12 37 44 15 73
Pityriasis Circinata 12

Classifications:



External Ids:

Disease Ontology 12 DOID:8892
ICD10 33 L42
ICD9CM 35 696.3
MeSH 44 D017515
NCIt 50 C26855
SNOMED-CT 68 156373006 77252004
KEGG 37 H01660
UMLS 73 C0032026

Summaries for Pityriasis Rosea

MalaCards based summary : Pityriasis Rosea, also known as pityriasis circinata, is related to aphthous stomatitis and human herpesvirus 8. An important gene associated with Pityriasis Rosea is HLA-DRB1 (Major Histocompatibility Complex, Class II, DR Beta 1), and among its related pathways/superpathways are Innate Immune System and Class I MHC mediated antigen processing and presentation. The drugs Tacrolimus and Petrolatum have been mentioned in the context of this disorder. Affiliated tissues include skin, bone and testes, and related phenotypes are Increased shRNA abundance (Z-score > 2) and Increased shRNA abundance (Z-score > 2)

Wikipedia : 76 Pityriasis rosea is a type of skin rash. Classically, it begins with a single red and slightly scaly... more...

Related Diseases for Pityriasis Rosea

Diseases related to Pityriasis Rosea via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 135)
# Related Disease Score Top Affiliating Genes
1 aphthous stomatitis 29.2 HLA-A HLA-B
2 human herpesvirus 8 28.8 HLA-A HLA-B HLA-C
3 pityriasis rotunda 11.5
4 sympathetic ophthalmia 10.4 HLA-C HLA-DRB1
5 limbic encephalitis with lgi1 antibodies 10.4 HLA-DQB1 HLA-DRB1
6 halo nevi 10.4 HLA-DRB1 HLA-DRB4
7 metal allergy 10.4 HLA-DQB1 HLA-DRB1
8 focal epithelial hyperplasia 10.4 HLA-DQB1 HLA-DRB1
9 hypersomnia 10.4 HLA-DQB1 HLA-DRB1
10 lichen planopilaris 10.4 HLA-DQB1 HLA-DRB1
11 rheumatoid vasculitis 10.4 CX3CL1 HLA-DRB1
12 type ii mixed cryoglobulinemia 10.4 HLA-DQB1 HLA-DRB1
13 beryllium disease 10.4 HLA-DQB1 HLA-DRB1
14 recurrent respiratory papillomatosis 10.4 HLA-DQB1 HLA-DRB1
15 autoimmune pancreatitis 10.4 HLA-DQB1 HLA-DRB1
16 chronic beryllium disease 10.4 HLA-DQB1 HLA-DRB1
17 lichen sclerosus 10.4 HLA-DQB1 HLA-DRB1
18 whipple disease 10.3 HLA-DQB1 HLA-DRB1
19 pediatric multiple sclerosis 10.3 HLA-DQB1 HLA-DRB1
20 osteonecrosis of the jaw 10.3 HLA-DQB1 HLA-DRB1
21 psoriasis 10.3
22 peanut allergy 10.3 HLA-DQB1 HLA-DRB1
23 microscopic polyangiitis 10.3 HLA-B HLA-DRB1
24 idiopathic inflammatory myopathy 10.3 HLA-B HLA-DRB1
25 hepatitis 10.3
26 dermatitis 10.3
27 oligoarticular juvenile idiopathic arthritis 10.3 HLA-DQB1 HLA-DRB1
28 severe hemophilia a 10.2 HLA-DQB1 HLA-DRB1
29 ocular cicatricial pemphigoid 10.2 HLA-DQB1 HLA-DRB1
30 hepatitis b 10.2
31 exanthem 10.2
32 syphilis 10.2
33 lichen planus 10.2
34 erythema multiforme 10.1
35 hepatitis c 10.1
36 influenza 10.1
37 herpes zoster 10.1
38 gianotti crosti syndrome 10.1
39 echinococcosis 10.0 HLA-B HLA-DRB1
40 hepatitis c virus 10.0
41 skin disease 10.0
42 bell's palsy 10.0
43 secondary syphilis 10.0
44 herpes simplex 10.0
45 cytomegalovirus retinitis 10.0 HLA-B HLA-DQB1
46 birdshot chorioretinopathy 9.9 HLA-A HLA-C
47 bladder cancer 9.9
48 multiple sclerosis 9.9
49 rheumatoid arthritis 9.9
50 lymphoma, hodgkin, classic 9.9

Graphical network of the top 20 diseases related to Pityriasis Rosea:



Diseases related to Pityriasis Rosea

Symptoms & Phenotypes for Pityriasis Rosea

GenomeRNAi Phenotypes related to Pityriasis Rosea according to GeneCards Suite gene sharing:

26 (show all 28)
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Increased shRNA abundance (Z-score > 2) GR00366-A-103 10.81 HLA-C HLA-A HLA-B
2 Increased shRNA abundance (Z-score > 2) GR00366-A-110 10.81 HLA-C HLA-A HLA-B
3 Increased shRNA abundance (Z-score > 2) GR00366-A-118 10.81 HLA-C HLA-A HLA-B
4 Increased shRNA abundance (Z-score > 2) GR00366-A-12 10.81 HLA-DRB4
5 Increased shRNA abundance (Z-score > 2) GR00366-A-124 10.81 HLA-C
6 Increased shRNA abundance (Z-score > 2) GR00366-A-127 10.81 HLA-DRB4
7 Increased shRNA abundance (Z-score > 2) GR00366-A-130 10.81 HLA-DRB4
8 Increased shRNA abundance (Z-score > 2) GR00366-A-137 10.81 HLA-DRB4
9 Increased shRNA abundance (Z-score > 2) GR00366-A-149 10.81 HLA-C
10 Increased shRNA abundance (Z-score > 2) GR00366-A-156 10.81 HLA-C HLA-A HLA-B
11 Increased shRNA abundance (Z-score > 2) GR00366-A-162 10.81 HLA-C
12 Increased shRNA abundance (Z-score > 2) GR00366-A-174 10.81 HLA-DRB4
13 Increased shRNA abundance (Z-score > 2) GR00366-A-177 10.81 HLA-DRB4
14 Increased shRNA abundance (Z-score > 2) GR00366-A-178 10.81 HLA-C HLA-A HLA-B
15 Increased shRNA abundance (Z-score > 2) GR00366-A-185 10.81 HLA-DRB4
16 Increased shRNA abundance (Z-score > 2) GR00366-A-19 10.81 HLA-C HLA-A HLA-B
17 Increased shRNA abundance (Z-score > 2) GR00366-A-196 10.81 HLA-DRB4
18 Increased shRNA abundance (Z-score > 2) GR00366-A-2 10.81 HLA-DRB4
19 Increased shRNA abundance (Z-score > 2) GR00366-A-202 10.81 HLA-C
20 Increased shRNA abundance (Z-score > 2) GR00366-A-31 10.81 HLA-C HLA-DRB4 HLA-A HLA-B
21 Increased shRNA abundance (Z-score > 2) GR00366-A-42 10.81 HLA-DRB4
22 Increased shRNA abundance (Z-score > 2) GR00366-A-46 10.81 HLA-DRB4
23 Increased shRNA abundance (Z-score > 2) GR00366-A-47 10.81 HLA-C
24 Increased shRNA abundance (Z-score > 2) GR00366-A-67 10.81 HLA-DRB4
25 Increased shRNA abundance (Z-score > 2) GR00366-A-7 10.81 HLA-C HLA-A HLA-B
26 Increased shRNA abundance (Z-score > 2) GR00366-A-70 10.81 HLA-DRB4
27 Increased shRNA abundance (Z-score > 2) GR00366-A-74 10.81 HLA-C HLA-A HLA-B
28 Increased shRNA abundance (Z-score > 2) GR00366-A-93 10.81 HLA-C

Drugs & Therapeutics for Pityriasis Rosea

Drugs for Pityriasis Rosea (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 14)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Tacrolimus Approved, Investigational Phase 4 104987-11-3 445643 439492
2
Petrolatum Approved, Investigational Phase 4 8009-03-8
3
Calcitriol Approved, Nutraceutical Phase 4 32222-06-3 134070 5280453
4
Vitamin D Approved, Nutraceutical, Vet_approved Phase 4 1406-16-2
5 Micronutrients Phase 4
6 Dermatologic Agents Phase 4
7 Trace Elements Phase 4
8 Vasoconstrictor Agents Phase 4
9 Emollients Phase 4
10 Vitamins Phase 4
11 Immunosuppressive Agents Phase 4
12 Bone Density Conservation Agents Phase 4
13 Calcineurin Inhibitors Phase 4
14 Calcium, Dietary Phase 4

Interventional clinical trials:


# Name Status NCT ID Phase Drugs
1 Clinical Trial of 0.0003% Calcitriol, 0.1% Tacrolimus, and Petrolatum for the Treatment of Pityriasis Alba Completed NCT01388517 Phase 4 Tacrolimus;Calcitriol;Petrolatum
2 Serum 25(OH) Vitamin D and Total Serum Immunoglobulin E Levels in Patients With Pityriasis Alba Active, not recruiting NCT03443765

Search NIH Clinical Center for Pityriasis Rosea

Inferred drug relations via UMLS 73 / NDF-RT 51 :


Cochrane evidence based reviews: pityriasis rosea

Genetic Tests for Pityriasis Rosea

Anatomical Context for Pityriasis Rosea

MalaCards organs/tissues related to Pityriasis Rosea:

41
Skin, Bone, Testes, Tongue, T Cells, Myeloid, Bone Marrow

Publications for Pityriasis Rosea

Articles related to Pityriasis Rosea:

(show top 50) (show all 441)
# Title Authors Year
1
Ibrutinib-associated pityriasis rosea-like rash. ( 29387749 )
2018
2
Pityriasis Rosea. ( 29431416 )
2018
3
Pityriasis rosea in a patient with retrovirus infection: a reply. ( 29599683 )
2018
4
Pityriasis Rosea in a Mother and her Daughter: A Case Report. ( 29644205 )
2018
5
Pityriasis rosea-like eruption associated with ondansetron use in pregnancy. ( 29520857 )
2018
6
Double-blind randomized placebo-controlled trial to evaluate the efficacy and safety of short-course low-dose oral prednisolone in pityriasis rosea. ( 29363373 )
2018
7
Geographic tonguelike presentation in a child with pityriasis rosea: Case report and review of oral manifestations of pityriasis rosea. ( 29436009 )
2018
8
Pityriasis Rosea: Diagnosis and Treatment. ( 29365241 )
2018
9
Efficacy and Safety of Indigo Naturalis in Combination with Narrow-Band Ultraviolet B for Treatment of Pityriasis Rosea: A Meta-Analysis. ( 29770152 )
2018
10
Relapsing Pityriasis Rosea With HHV-7 Reactivation in an 11-Year-Old Girl. ( 29674359 )
2018
11
Pityriasis Rosea. ( 29365248 )
2018
12
Pityriasis Rosea during Pregnancy: Major and Minor Alarming Signs. ( 29936509 )
2018
13
Higher Expression of Toll-like Receptors 3, 7, 8, and 9 in Pityriasis Rosea. ( 28192646 )
2017
14
Association of HLA-DQB1*03:03 with pityriasis rosea in Chinese patients. ( 29222811 )
2017
15
Persistent and Generalized Purpuric Lesions in an Adolescent: A Rare Atypical Form of Pityriasis Rosea. ( 28584764 )
2017
16
Pityriasis rosea in a patient with retrovirus infection and a history of syphilis and positive results of infection with hepatitis A virus, hepatitis B virus and hepatitis C virus. ( 28670260 )
2017
17
The role of interleukin-22 in pityriasis rosea. ( 27862158 )
2017
18
Can Unilateral Pityriasis Rosea be Considered a Form of Superimposed Lateralized Exanthem? ( 28764276 )
2017
19
Pediatric pityriasis rosea ( 29156879 )
2017
20
Pityriasis, Rosea ( 28846360 )
2017
21
Pityriasis Rosea: An Update on Etiopathogenesis and Management of Difficult Aspects - A Reply. ( 28216734 )
2017
22
Cutaneous plasmacytosis resembling pityriasis rosea in a 66-year-old white woman: A rare disease presenting in an unusual patient demographic. ( 28203625 )
2017
23
Occult Hepatitis B Virus Infections (Often with Human Herpesvirus 7 Co-Infection) Detected in<i>Pityriasis rosea</i>Patients: A Pilot Study. ( 29263533 )
2017
24
Concurrent pityriasis rosea and Bell's palsy. ( 28115404 )
2017
25
Pityriasis rosea-like eruption induced by isotretinoin. ( 28359163 )
2017
26
A retrospective study on rapid plasma reagin testing in patients with Pityriasis rosea. ( 28345391 )
2017
27
Diagnosis and management of pityriasis rosea. ( 28002142 )
2017
28
Clinical variants of pityriasis rosea. ( 28685133 )
2017
29
Atypical presentations of pityriasis rosea: a reply. ( 29469755 )
2017
30
Oropharyngeal lesions in pityriasis rosea. ( 28728872 )
2017
31
Recurrent pityriasis rosea: A case report. ( 29182459 )
2017
32
Simultaneous occurrence of hand foot and mouth disease and pityriasis rosea. ( 29144097 )
2017
33
The role of dermoscopy using a triple light source in the diagnosis of pityriasis rosea: an observational pilot study. ( 28188635 )
2017
34
Unique clinical presentations of pityriasis rosea: aphthous ulcers, vesicles and inverse distribution of lesions. ( 28329497 )
2017
35
Unilateral pityriasis rosea in a child: A rare clinical presentation. ( 29276879 )
2017
36
Scabies Surrepticius: Scabies Masquerading as Pityriasis Rosea. ( 29492350 )
2017
37
Atypical pityriasis rosea presenting with a herald patch lesion on the healed site of herpes zoster: Wolf's isotopic response. ( 26678150 )
2016
38
Pityriasis Rosea: An Update on Etiopathogenesis and Management of Difficult Aspects. ( 27512182 )
2016
39
Atypical Pityriasis Rosea with Unilateral Presentation. ( 28208986 )
2016
40
Pityriasis rosea along Blaschko's lines: A rare variant. ( 27852994 )
2016
41
Is There a Link between Human Herpesvirus Infection and Toll-like Receptors in the Pathogenesis of Pityriasis Rosea? A Case-control Study. ( 28128079 )
2016
42
A position statement on the management of patients with pityriasis rosea. ( 27406919 )
2016
43
Anesthetic Considerations for Neuraxial Anesthesia in Pregnant Patients With Pityriasis Rosea With Skin Lesions Covering the Lumbar Spine. ( 27513966 )
2016
44
The Oxidant and Antioxidant Status in Pityriasis Rosea. ( 26955119 )
2016
45
Pityriasis rosea in pregnancy: report of a spousal occurrence and craniosynostosis in the healthy newborn. ( 27648382 )
2016
46
Acyclovir is not effective in pityriasis rosea: Results of a randomized, triple-blind, placebo-controlled trial. ( 27212277 )
2016
47
Pityriasis Rosea: A Comprehensive Classification. ( 27096928 )
2016
48
Gestational Pityriasis Rosea: Suggestions for Approaching Affected Pregnant Women. ( 28128088 )
2016
49
Pityriasis rosea: a natural history of pediatric cases in theCentral Anatolia Region of Turkey. ( 28081320 )
2016
50
Salute sign: A nonambiguous histopathological sign in pityriasis rosea. ( 27990399 )
2016

Variations for Pityriasis Rosea

Expression for Pityriasis Rosea

Search GEO for disease gene expression data for Pityriasis Rosea.

Pathways for Pityriasis Rosea

Pathways related to Pityriasis Rosea according to GeneCards Suite gene sharing:

(show all 36)
# Super pathways Score Top Affiliating Genes
1
Show member pathways
13.74 HLA-A HLA-B HLA-C HLA-DQB1 HLA-DRB1 HLA-DRB4
2
Show member pathways
13.15 HLA-A HLA-B HLA-C HLA-DQB1 HLA-DRB1 HLA-DRB4
3
Show member pathways
13.06 HLA-A HLA-B HLA-C HLA-DQB1 HLA-DRB1 HLA-DRB4
4
Show member pathways
12.71 HLA-A HLA-B HLA-C HLA-DQB1 HLA-DRB1 HLA-DRB4
5
Show member pathways
12.65 HLA-A HLA-B HLA-C HLA-DQB1 HLA-DRB1 HLA-DRB4
6
Show member pathways
12.54 HLA-DQB1 HLA-DRB1 HLA-DRB4
7
Show member pathways
12.53 HLA-A HLA-B HLA-C HLA-DQB1 HLA-DRB1 HLA-DRB4
8
Show member pathways
12.43 HLA-A HLA-B HLA-C
9
Show member pathways
12.38 HLA-DQB1 HLA-DRB1 HLA-DRB4
10
Show member pathways
12.36 HLA-A HLA-B HLA-C
11
Show member pathways
12.31 HLA-A HLA-B HLA-C
12
Show member pathways
12.29 HLA-A HLA-B HLA-C HLA-DQB1 HLA-DRB1 HLA-DRB4
13
Show member pathways
12.27 HLA-A HLA-B HLA-C
14
Show member pathways
12.24 HLA-DQB1 HLA-DRB1 HLA-DRB4
15 12.2 HLA-A HLA-B HLA-C
16
Show member pathways
12.19 HLA-DQB1 HLA-DRB1 HLA-DRB4
17
Show member pathways
12.15 HLA-DQB1 HLA-DRB1 HLA-DRB4
18 12.14 HLA-A HLA-B HLA-C HLA-DQB1 HLA-DRB1 HLA-DRB4
19 12.1 HLA-A HLA-B HLA-C
20
Show member pathways
12.06 HLA-DQB1 HLA-DRB1 HLA-DRB4
21 12.04 HLA-DQB1 HLA-DRB1 HLA-DRB4
22
Show member pathways
12.02 HLA-DQB1 HLA-DRB1 HLA-DRB4
23
Show member pathways
11.99 HLA-DQB1 HLA-DRB1 HLA-DRB4
24 11.98 HLA-A HLA-B HLA-C
25 11.94 HLA-A HLA-B HLA-C HLA-DQB1 HLA-DRB1 HLA-DRB4
26 11.89 HLA-A HLA-B HLA-C
27
Show member pathways
11.78 HLA-DQB1 HLA-DRB1 HLA-DRB4
28 11.75 HLA-DQB1 HLA-DRB1 HLA-DRB4
29 11.75 HLA-DQB1 HLA-DRB1 HLA-DRB4
30 11.71 HLA-DQB1 HLA-DRB1 HLA-DRB4
31 11.67 HLA-DQB1 HLA-DRB1 HLA-DRB4
32 11.61 HLA-A HLA-B HLA-C HLA-DQB1 HLA-DRB1 HLA-DRB4
33 11.55 HLA-DQB1 HLA-DRB1 HLA-DRB4
34 11.43 HLA-DQB1 HLA-DRB1 HLA-DRB4
35 11.26 HLA-A HLA-B HLA-C HLA-DQB1 HLA-DRB1 HLA-DRB4
36 11.03 HLA-A HLA-B HLA-C

GO Terms for Pityriasis Rosea

Cellular components related to Pityriasis Rosea according to GeneCards Suite gene sharing:

(show all 16)
# Name GO ID Score Top Affiliating Genes
1 Golgi apparatus GO:0005794 9.86 HLA-A HLA-B HLA-C HLA-DRB1
2 cell surface GO:0009986 9.8 CX3CL1 HLA-A HLA-B HLA-C HLA-DRB1
3 lysosomal membrane GO:0005765 9.72 HLA-DQB1 HLA-DRB1 HLA-DRB4
4 early endosome membrane GO:0031901 9.7 HLA-A HLA-B HLA-C
5 trans-Golgi network membrane GO:0032588 9.69 HLA-DQB1 HLA-DRB1 HLA-DRB4
6 recycling endosome membrane GO:0055038 9.67 HLA-A HLA-B HLA-C
7 phagocytic vesicle membrane GO:0030670 9.65 HLA-A HLA-B HLA-C
8 endocytic vesicle membrane GO:0030666 9.63 HLA-DQB1 HLA-DRB1 HLA-DRB4
9 Golgi membrane GO:0000139 9.63 HLA-A HLA-B HLA-C HLA-DQB1 HLA-DRB1 HLA-DRB4
10 transport vesicle membrane GO:0030658 9.61 HLA-DQB1 HLA-DRB1 HLA-DRB4
11 clathrin-coated endocytic vesicle membrane GO:0030669 9.54 HLA-DQB1 HLA-DRB1 HLA-DRB4
12 MHC class II protein complex GO:0042613 9.5 HLA-DQB1 HLA-DRB1 HLA-DRB4
13 MHC class I protein complex GO:0042612 9.43 HLA-A HLA-B HLA-C
14 ER to Golgi transport vesicle membrane GO:0012507 9.43 HLA-A HLA-B HLA-C HLA-DQB1 HLA-DRB1 HLA-DRB4
15 integral component of lumenal side of endoplasmic reticulum membrane GO:0071556 9.1 HLA-A HLA-B HLA-C HLA-DQB1 HLA-DRB1 HLA-DRB4
16 plasma membrane GO:0005886 10.08 CX3CL1 HLA-A HLA-B HLA-C HLA-DQB1 HLA-DRB1

Biological processes related to Pityriasis Rosea according to GeneCards Suite gene sharing:

(show all 17)
# Name GO ID Score Top Affiliating Genes
1 immune system process GO:0002376 9.85 HLA-A HLA-B HLA-C HLA-DRB1
2 viral process GO:0016032 9.83 HLA-A HLA-B HLA-C HLA-DRB1
3 regulation of immune response GO:0050776 9.74 HLA-A HLA-B HLA-C
4 T cell receptor signaling pathway GO:0050852 9.73 HLA-DQB1 HLA-DRB1 HLA-DRB4
5 antigen processing and presentation of exogenous peptide antigen via MHC class II GO:0019886 9.69 HLA-DQB1 HLA-DRB1 HLA-DRB4
6 T cell costimulation GO:0031295 9.67 HLA-DQB1 HLA-DRB1 HLA-DRB4
7 antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent GO:0002479 9.65 HLA-A HLA-B HLA-C
8 immune response GO:0006955 9.63 CX3CL1 HLA-A HLA-B HLA-C HLA-DQB1 HLA-DRB1
9 type I interferon signaling pathway GO:0060337 9.58 HLA-A HLA-B HLA-C
10 antigen processing and presentation of peptide or polysaccharide antigen via MHC class II GO:0002504 9.54 HLA-DQB1 HLA-DRB1
11 antigen processing and presentation of peptide antigen via MHC class I GO:0002474 9.5 HLA-A HLA-B HLA-C
12 protection from natural killer cell mediated cytotoxicity GO:0042270 9.46 HLA-A HLA-B
13 humoral immune response mediated by circulating immunoglobulin GO:0002455 9.43 HLA-DQB1 HLA-DRB1
14 antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent GO:0002480 9.43 HLA-A HLA-B HLA-C
15 immunoglobulin production involved in immunoglobulin mediated immune response GO:0002381 9.37 HLA-DQB1 HLA-DRB1
16 antigen processing and presentation GO:0019882 9.35 HLA-A HLA-B HLA-C HLA-DQB1 HLA-DRB1
17 interferon-gamma-mediated signaling pathway GO:0060333 9.1 HLA-A HLA-B HLA-C HLA-DQB1 HLA-DRB1 HLA-DRB4

Molecular functions related to Pityriasis Rosea according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 signaling receptor binding GO:0005102 9.26 CX3CL1 HLA-A HLA-B HLA-C
2 MHC class II receptor activity GO:0032395 9.16 HLA-DQB1 HLA-DRB1
3 peptide antigen binding GO:0042605 9.02 HLA-A HLA-B HLA-C HLA-DQB1 HLA-DRB1

Sources for Pityriasis Rosea

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....